Calin Dan Dumitru
Thomas Jefferson University
Network
Latest external collaboration on country level. Dive into details by clicking on the dots.
Publication
Featured researches published by Calin Dan Dumitru.
Proceedings of the National Academy of Sciences of the United States of America | 2002
George A. Calin; Calin Dan Dumitru; Masayoshi Shimizu; Roberta Bichi; Simona Zupo; Evan Noch; Hansjuerg Aldler; Sashi Rattan; Michael J. Keating; Kanti R. Rai; Laura Z. Rassenti; Thomas J. Kipps; Massimo Negrini; Florencia Bullrich; Carlo M. Croce
Micro-RNAs (miR genes) are a large family of highly conserved noncoding genes thought to be involved in temporal and tissue-specific gene regulation. MiRs are transcribed as short hairpin precursors (≈70 nt) and are processed into active 21- to 22-nt RNAs by Dicer, a ribonuclease that recognizes target mRNAs via base-pairing interactions. Here we show that miR15 and miR16 are located at chromosome 13q14, a region deleted in more than half of B cell chronic lymphocytic leukemias (B-CLL). Detailed deletion and expression analysis shows that miR15 and miR16 are located within a 30-kb region of loss in CLL, and that both genes are deleted or down-regulated in the majority (≈68%) of CLL cases.
Journal of Immunology | 2007
Esmerina Tili; Jean-Jacques Michaille; Amelia Cimino; Stefan Costinean; Calin Dan Dumitru; Brett Adair; Muller Fabbri; Hannes Alder; Chang Gong Liu; George A. Calin; Carlo M. Croce
We report here that miR-155 and miR-125b play a role in innate immune response. LPS stimulation of mouse Raw 264.7 macrophages resulted in the up-regulation of miR-155 and down-regulation of miR-125b levels. The same changes also occurred when C57BL/6 mice were i.p. injected with LPS. Furthermore, the levels of miR-155 and miR-125b in Raw 264.7 cells displayed oscillatory changes in response to TNF-α. These changes were impaired by pretreating the cells with the proteasome inhibitor MG-132, suggesting that these two microRNAs (miRNAs) may be at least transiently under the direct control of NF-κB transcriptional activity. We show that miR-155 most probably directly targets transcript coding for several proteins involved in LPS signaling such as the Fas-associated death domain protein (FADD), IκB kinase ε (IKKε), and the receptor (TNFR superfamily)-interacting serine-threonine kinase 1 (Ripk1) while enhancing TNF-α translation. In contrast, miR-125b targets the 3′-untranslated region of TNF-α transcripts; therefore, its down-regulation in response to LPS may be required for proper TNF-α production. Finally, Eμ-miR-155 transgenic mice produced higher levels of TNF-α when exposed to LPS and were hypersensitive to LPS/d-galactosamine-induced septic shock. Altogether, our data suggest that the LPS/TNF-α-dependent regulation of miR-155 and miR-125b may be implicated in the response to endotoxin shock, thus offering new targets for drug design.
Cell | 2000
Calin Dan Dumitru; Jeffrey D. Ceci; Christos Tsatsanis; Dimitris Kontoyiannis; Konstantinos Stamatakis; Jun Hsiang Lin; Christos Patriotis; Nancy A. Jenkins; Neal G. Copeland; George Kollias; Philip N. Tsichlis
Abstract Tpl 2 knockout mice produce low levels of TNF-α when exposed to lipopolysaccharide (LPS) and they are resistant to LPS/D-Galactosamine-induced pathology. LPS stimulation of peritoneal macrophages from these mice did not activate MEK1, ERK1, and ERK2 but did activate JNK, p38 MAPK, and NF-κB. The block in ERK1 and ERK2 activation was causally linked to the defect in TNF-α induction by experiments showing that normal murine macrophages treated with the MEK inhibitor PD98059 exhibit a similar defect. Deletion of the AU-rich motif in the TNF-α mRNA minimized the effect of Tpl2 inactivation on the induction of TNF-α. Subcellular fractionation of LPS-stimulated macrophages revealed that LPS signals transduced by Tpl2 specifically promote the transport of TNF-α mRNA from the nucleus to the cytoplasm.
The EMBO Journal | 2002
Aristides G. Eliopoulos; Calin Dan Dumitru; Chun‐Chi Wang; Jeonghee Cho; Philip N. Tsichlis
Macrophage activation by bacterial lipopolysaccharide (LPS) promotes the secretion of pro‐inflammatory cytokines, such as tumor necrosis factor‐α (TNF‐α) and interleukin‐1β (IL‐1β), and of secondary mediators, such as leukotrienes and prostaglandins (PGs). Mice lacking the gene encoding the serine/threonine protein kinase Tpl2/Cot produce low levels of TNF‐α in response to LPS because of an ERK‐dependent post‐transcriptional defect, and they are resistant to LPS/D‐galactosamine‐induced endotoxin shock. In this study we demonstrate that prostaglandin E2 and its regulatory enzyme, COX‐2, are also targets of Tpl2‐transduced LPS signals in bone marrow‐derived mouse macrophages. Thus, LPS‐stimulated Tpl2−/− macrophages express low levels of COX‐2 and PGE2, compared with wild‐type Tpl2+/+ cells. The ability of Tpl2 to regulate COX‐2 expression depends on ERK signals that activate p90Rsk and Msk1, which in turn phosphorylate CREB, a key regulator of COX‐2 transcription. These data identify physiological targets of Tpl2 signaling downstream of ERK and further implicate Tpl2 in the pathophysiology of inflammation.
The EMBO Journal | 2003
Aristides G. Eliopoulos; Chun‐Chi Wang; Calin Dan Dumitru; Philip N. Tsichlis
Macrophages from Tpl2 knockout (Tpl2−/−) mice exhibit a defect in ERK activation by lipopolysaccharide (LPS). This impairs the nucleocytoplasmic transport of the tumor necrosis factor α (TNF‐α) mRNA and prevents the induction of TNF‐α by LPS. As a result, Tpl2−/− mice are resistant to LPS/D‐galactosamine‐induced shock. We demonstrate that Tpl2 is essential for ERK signals transduced by members of the TNF receptor superfamily, such as CD40 and the TNF receptor 1. Thus, ERK activation was impaired in Tpl2−/− B cells and macrophages stimulated with agonistic CD40 antibody or TNF‐α, whereas the induction of other mitogen‐activated protein kinases, such as JNK and p38, and the activation of NF‐κB were unaffected. Tpl2 was recruited to a CD40/TRAF6 complex in response to CD40 stimulation. Moreover, TRAF6, which when overexpressed activates ERK, failed to do so in Tpl2−/− cells. The selective signaling defect resulting from the inactivation of Tpl2 allowed us to demonstrate that CD40‐mediated ERK activation contributes to immunoglobulin production but is not essential for B‐cell proliferation.
Proceedings of the National Academy of Sciences of the United States of America | 2011
Tung O. Chan; Jin Zhang; Ulrich Rodeck; John M. Pascal; Roger S. Armen; Maureen Spring; Calin Dan Dumitru; Valerie Myers; Xue Li; Joseph Y. Cheung; Arthur M. Feldman
Phosphorylation of a threonine residue (T308 in Akt1) in the activation loop of Akt kinases is a prerequisite for deregulated Akt activity frequently observed in neoplasia. Akt phosphorylation in vivo is balanced by the opposite activities of kinases and phosphatases. Here we describe that targeting Akt kinase to the cell membrane markedly reduced sensitivity of phosphorylated Akt to dephosphorylation by protein phosphatase 2A. This effect was amplified by occupancy of the ATP binding pocket by either ATP or ATP-competitive inhibitors. Mutational analysis revealed that R273 in Akt1 and the corresponding R274 in Akt2 are essential for shielding T308 in the activation loop against dephosphorylation. Thus, occupancy of the nucleotide binding pocket of Akt kinases enables intramolecular interactions that restrict phosphatase access and sustain Akt phosphorylation. This mechanism provides an explanation for the “paradoxical” Akt hyperphosphorylation induced by ATP-competitive inhibitor, A-443654. The lack of phosphatase resistance further contributes insight into the mechanism by which the human Akt2 R274H missense mutation may cause autosomal-dominant diabetes mellitus.
Proceedings of the National Academy of Sciences of the United States of America | 2004
George A. Calin; Cinzia Sevignani; Calin Dan Dumitru; Terry Hyslop; Evan Noch; Sai Yendamuri; Masayoshi Shimizu; Sashi Rattan; Florencia Bullrich; Massimo Negrini; Carlo M. Croce
Proceedings of the National Academy of Sciences of the United States of America | 2004
George A. Calin; Chang Gong Liu; Cinzia Sevignani; Manuela Ferracin; Nadia Felli; Calin Dan Dumitru; Masayoshi Shimizu; Amelia Cimmino; Simona Zupo; Marielia Dono; Marie Dell'Aquila; Hansjuerg Alder; Laura Z. Rassenti; Thomas J. Kipps; Florencia Bullrich; Massimo Negrini; Carlo M. Croce
Proceedings of the National Academy of Sciences of the United States of America | 2004
Chang Gong Liu; George A. Calin; Brian Meloon; Nir Gamliel; Cinzia Sevignani; Manuela Ferracin; Calin Dan Dumitru; Masayoshi Shimizu; Simona Zupo; Mariella Dono; Hansjuerg Alder; Florencia Bullrich; Massimo Negrini; Carlo M. Croce
The New England Journal of Medicine | 2005
George A. Calin; Francesco Trapasso; Masayoshi Shimizu; Calin Dan Dumitru; Sai Yendamuri; Andrew K. Godwin; Manuela Ferracin; Guido Bernardi; Devjani Chatterjee; Gustavo Baldassarre; Shashi Rattan; Hansjuerg Alder; Hideaki Mabuchi; Takeshi Shiraishi; Lise Lotte Hansen; Jens Overgaard; Vlad Herlea; Francesca Romana Mauro; Guillaume Dighiero; Benjamin Movsas; Laura Z. Rassenti; Thomas J. Kipps; Raffaele Baffa; Alfredo Fusco; Masaki Mori; Giandomenico Russo; Chang Gong Liu; Donna Neuberg; Florencia Bullrich; Massimo Negrini